Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Capacite Infraprojects share price dropped nearly 15% after a decline in Q3FY25 EBITDA margins to 16.7%. Despite a 77% ...
A long bear candle was formed on the weekly chart, which indicates a reversal on the downside after the two weeks of upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback